2025 France Antipyretic Analgesic Active Pharmaceutical Ingredients Market Revenue Opportunities Report
Description
The 2025 France Antipyretic Analgesic Active Pharmaceutical Ingredients Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antipyretic Analgesic Active Pharmaceutical Ingredients Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Antipyretic Analgesic Active Pharmaceutical Ingredients (API) market in France are Seqens, EuroAPI, Axplora, and Sanofi (through EuroAPI). Seqens leads in paracetamol and aspirin manufacturing, with a French plant producing up to 15 kT of paracetamol annually by 2026, using an innovative eco-friendly process reducing CO2 emissions by 75%. EuroAPI, headquartered in Paris, is one of the world's largest small-molecule API producers, with multiple French plants and a portfolio of over 200 APIs. It was spun off from Sanofi and benefits from government support to strengthen Europe's pharmaceutical supply chain.
Axplora operates several CDMO sites in France, such as Le Mans and Chasse-sur-Rhône, offering extensive API development and manufacturing services, including high-potency APIs relevant to analgesics. Sanofi, historically a major player, consolidated its API production under EuroAPI to enhance agility and market responsiveness. Together, these companies form key pillars of the French and European antipyretic and analgesic API landscape, supported by regulatory certifications and strategic investments to bolster health sovereignty and sustainability goals in France.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antipyretic Analgesic Active Pharmaceutical Ingredients Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Antipyretic Analgesic Active Pharmaceutical Ingredients (API) market in France are Seqens, EuroAPI, Axplora, and Sanofi (through EuroAPI). Seqens leads in paracetamol and aspirin manufacturing, with a French plant producing up to 15 kT of paracetamol annually by 2026, using an innovative eco-friendly process reducing CO2 emissions by 75%. EuroAPI, headquartered in Paris, is one of the world's largest small-molecule API producers, with multiple French plants and a portfolio of over 200 APIs. It was spun off from Sanofi and benefits from government support to strengthen Europe's pharmaceutical supply chain.
Axplora operates several CDMO sites in France, such as Le Mans and Chasse-sur-Rhône, offering extensive API development and manufacturing services, including high-potency APIs relevant to analgesics. Sanofi, historically a major player, consolidated its API production under EuroAPI to enhance agility and market responsiveness. Together, these companies form key pillars of the French and European antipyretic and analgesic API landscape, supported by regulatory certifications and strategic investments to bolster health sovereignty and sustainability goals in France.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
